• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过优化 2-氨基哒嗪系列化合物在寄生虫生命周期中的水溶性和效力,鉴定出一种有潜力的抗疟药物候选物。

Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.

机构信息

Drug Discovery and Development Center (H3D), Department of Chemistry, University of Cape Town , Rondebosch 7701, South Africa.

Syngene International Ltd. , Biocon Park, Plot No. 2 & 3, Bommasandra IV Phase, Jigani Link Road, Bangalore 560099, India.

出版信息

J Med Chem. 2016 Nov 10;59(21):9890-9905. doi: 10.1021/acs.jmedchem.6b01265. Epub 2016 Oct 26.

DOI:10.1021/acs.jmedchem.6b01265
PMID:27748596
Abstract

Introduction of water-solubilizing groups on the 5-phenyl ring of a 2-aminopyrazine series led to the identification of highly potent compounds against the blood life-cycle stage of the human malaria parasite Plasmodium falciparum. Several compounds displayed high in vivo efficacy in two different mouse models for malaria, P. berghei-infected mice and P. falciparum-infected NOD-scid IL-2Rγ mice. One of the frontrunners, compound 3, was identified to also have good pharmacokinetics and additionally very potent activity against the liver and gametocyte parasite life-cycle stages.

摘要

在 2-氨基吡嗪系列的 5-苯基环上引入水溶性基团,发现了对恶性疟原虫(Plasmodium falciparum)血期具有高活性的化合物。几种化合物在两种不同的疟疾小鼠模型(感染伯氏疟原虫的小鼠和感染疟原虫的 NOD-scid IL-2Rγ小鼠)中表现出高体内疗效。其中一个先导化合物 3 还具有良好的药代动力学特性,并且对肝期和配子体期寄生虫也具有很强的活性。

相似文献

1
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle.通过优化 2-氨基哒嗪系列化合物在寄生虫生命周期中的水溶性和效力,鉴定出一种有潜力的抗疟药物候选物。
J Med Chem. 2016 Nov 10;59(21):9890-9905. doi: 10.1021/acs.jmedchem.6b01265. Epub 2016 Oct 26.
2
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines.一种新型吡唑并吡啶,基于对近期发现的抗疟咪唑并哒嗪核心结构进行的构效关系研究,在感染伯氏疟原虫和恶性疟原虫的小鼠模型中具有体内活性。
J Med Chem. 2015 Nov 12;58(21):8713-22. doi: 10.1021/acs.jmedchem.5b01605. Epub 2015 Nov 2.
3
Discovery and optimisation studies of antimalarial phenotypic hits.抗疟表型活性物质的发现与优化研究。
Eur J Med Chem. 2015 Oct 20;103:530-8. doi: 10.1016/j.ejmech.2015.08.044. Epub 2015 Sep 9.
4
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model.抗疟吡啶并[1,2 - a]苯并咪唑类化合物:先导化合物优化、寄生虫生命周期阶段分布、作用机制评估、杀灭动力学以及小鼠模型中的体内口服疗效
J Med Chem. 2017 Feb 23;60(4):1432-1448. doi: 10.1021/acs.jmedchem.6b01641. Epub 2017 Feb 7.
5
Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.围绕抗疟 3,5-二芳基氨基嘧啶的 2-氨基基团和吡啶核心的构效关系研究,产生了具有口服体内活性的新型吡嗪类似物系列。
J Med Chem. 2013 Nov 14;56(21):8860-71. doi: 10.1021/jm401278d. Epub 2013 Oct 29.
6
Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a softfocus kinase library: part 2.抗疟原虫咪唑并吡啶嗪类化合物的高通量筛选软焦点激酶文库的药物化学优化:第 2 部分。
J Med Chem. 2014 Nov 13;57(21):8839-48. doi: 10.1021/jm500887k. Epub 2014 Oct 23.
7
Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.新型抗疟 1-芳基-3-取代丙醇衍生物的构效关系:合成、初步毒性特征分析、寄生虫生活史阶段研究、靶点探索和靶向递药。
Eur J Med Chem. 2018 May 25;152:489-514. doi: 10.1016/j.ejmech.2018.04.038. Epub 2018 Apr 24.
8
3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.3,5-双(亚苄基)-4-哌啶酮及相关的 N-酰基类似物:一组针对恶性疟原虫肝期的新型抗疟药物。
Bioorg Med Chem. 2013 Dec 1;21(23):7250-6. doi: 10.1016/j.bmc.2013.09.065. Epub 2013 Oct 8.
9
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.具有口服活性的抗疟 3,5-取代 2-氨基吡啶的构效关系研究。
J Med Chem. 2012 Dec 27;55(24):11022-30. doi: 10.1021/jm301476b. Epub 2012 Dec 14.
10
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and Efficacy in the NSG Mouse Model.鉴定具有快速杀伤动力学和在 NSG 小鼠模型中疗效的 2,4-二取代咪唑并吡啶类化合物作为疟原虫血红素聚合抑制剂。
J Med Chem. 2020 Nov 12;63(21):13013-13030. doi: 10.1021/acs.jmedchem.0c01411. Epub 2020 Oct 25.

引用本文的文献

1
The Importance of Murine Models in Determining In Vivo Pharmacokinetics, Safety, and Efficacy in Antimalarial Drug Discovery.小鼠模型在抗疟药物发现中确定体内药代动力学、安全性和疗效方面的重要性。
Pharmaceuticals (Basel). 2025 Mar 18;18(3):424. doi: 10.3390/ph18030424.
2
Dose-fractionation studies of a phosphatidylinositol 4-kinase inhibitor in a humanized mouse model of malaria.疟疾人源化小鼠模型中磷脂酰肌醇 4-激酶抑制剂的剂量分割研究。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0084224. doi: 10.1128/aac.00842-24. Epub 2024 Aug 28.
3
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of cysteine protease inhibitors for the treatment of malaria.
重新研究吡嗪的二苯甲基哌嗪类似物作为治疗疟疾的新型半胱氨酸蛋白酶抑制剂。
RSC Med Chem. 2024 Feb 1;15(3):1022-1037. doi: 10.1039/d3md00490b. eCollection 2024 Mar 20.
4
Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model.从标准化的恶性疟原虫人源化小鼠模型预测最佳抗疟药物组合。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0157422. doi: 10.1128/aac.01574-22. Epub 2023 May 3.
5
Development of Combretastatin A-4 Analogues as Potential Anticancer Agents with Improved Aqueous Solubility.开发具有改善水溶性的 Combretastatin A-4 类似物作为潜在的抗癌剂。
Molecules. 2023 Feb 10;28(4):1717. doi: 10.3390/molecules28041717.
6
The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.疟疾药品基金会的“疟疾药盒”中包含有抑制恶性疟原虫血期寄生虫蛋白分泌的抑制剂。
Traffic. 2022 Sep;23(9):442-461. doi: 10.1111/tra.12862. Epub 2022 Aug 15.
7
Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) Centre.整体药物发现与开发(H3D)中心的非洲主导药物发现创新经验。
ACS Med Chem Lett. 2022 Jul 11;13(8):1221-1230. doi: 10.1021/acsmedchemlett.2c00142. eCollection 2022 Aug 11.
8
Harmonizing solubility measurement to lower inter-laboratory variance - progress of consortium of biopharmaceutical tools (CoBiTo) in Japan.协调溶解度测量以降低实验室间差异——日本生物制药工具联盟(CoBiTo)的进展
ADMET DMPK. 2019 Aug 5;7(3):183-195. doi: 10.5599/admet.704. eCollection 2019.
9
An Update on Development of Small-Molecule Plasmodial Kinase Inhibitors.小分子疟原虫激酶抑制剂的研究进展。
Molecules. 2020 Nov 7;25(21):5182. doi: 10.3390/molecules25215182.
10
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and Efficacy in the NSG Mouse Model.鉴定具有快速杀伤动力学和在 NSG 小鼠模型中疗效的 2,4-二取代咪唑并吡啶类化合物作为疟原虫血红素聚合抑制剂。
J Med Chem. 2020 Nov 12;63(21):13013-13030. doi: 10.1021/acs.jmedchem.0c01411. Epub 2020 Oct 25.